![]() |
Engineered variant of recombinant human fibroblast growth factor 19 |
---|---|
Trade Name | |
Orphan Indication | Primary biliary cirrhosis |
USA Market Approval | USA |
USA Designation Date | 2014-02-06 00:00:00 |
Sponsor | NGM Biopharmaceuticals, Inc.;630 Gateway Blvd;South San Francisco, California, 94080 |